VCYT
Veracyte Inc
47.70$
+4.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 30.6% | 29.9% | 35.5% | 31.9% | 31.8% | 33.6% | 30.5% | 31.0% | 30.8% | 25.6% | 27.7% | 27.8% | 27.9% | |
| 69.4% | 70.1% | 64.5% | 68.1% | 68.2% | 66.4% | 69.5% | 69.0% | 69.2% | 74.4% | 72.3% | 72.2% | 72.1% | |
| 14.8% | 19.0% | 16.5% | 14.4% | 15.2% | 16.3% | 15.5% | 12.5% | 12.1% | 14.8% | 19.5% | 19.6% | 16.6% | |
| 18.1% | 41.9% | 44.3% | 41.0% | 34.9% | 39.7% | 45.7% | 10.6% | 32.8% | 1.0% | 17.0% | 18.3% | 17.0% | |
| 104.6% | 106.2% | 69.3% | 64.1% | 57.8% | 62.9% | 66.9% | 73.0% | 51.8% | 56.0% | 55.2% | 56.9% | 55.1% | |
| -35.2% | -36.2% | -4.8% | 4.0% | 10.4% | 3.5% | 2.5% | -4.0% | 17.4% | 18.4% | 17.1% | 15.3% | 17.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -33.0% | -31.0% | -2.0% | 6.4% | 14.5% | 2.9% | 6.5% | 1.0% | 14.3% | 28.9% | 21.6% | 12.9% | 19.4% | |
| -0.2% | -2.2% | 0.0% | 1.4% | 1.5% | -1.4% | 0.3% | 1.7% | -0.2% | -0.4% | 0.9% | -4.0% | -1.0% | |
| -32.9% | -28.8% | -1.9% | 5.0% | 13.1% | 4.3% | 6.2% | -0.8% | 14.5% | 29.3% | 20.6% | 17.0% | 20.4% | |
| -24.9% | -24.6% | 2.0% | 11.4% | 19.6% | 8.2% | 5.7% | 5.2% | 18.3% | 32.7% | 25.5% | 16.2% | 23.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.